stockrowThe Cooper Companies, Inc.
COO Healthcare Medical Instruments & Supplies
The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024.
- Revenue
- +0.56%
- EPS
- +357.1%
- Free cash flow
- +66.0%
- Total debt
- +2.66%
Quarter to July 2026, against a year earlier
Follow COO
Alert me
The Cooper Companies, Inc. (COO) Return on equity
The Cooper Companies, Inc.'s return on equity over the twelve months to 31 July 2026 was 6.84%, up 2.2 percentage points from fiscal 2025 (4.59%). Over the past ten years it has ranged from 4.00% (fiscal 2023) to 54.7% (fiscal 2021); the current reading is higher than 27% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 4.59% | (0.43) |
| FY2024 | 5.02% | 1.02 |
| FY2023 | 4.00% | (1.47) |
| FY2022 | 5.47% | (49.23) |
| FY2021 | 54.7% | 48.30 |
| FY2020 | 6.40% | (7.06) |
| FY2019 | 13.5% | 9.14 |
| FY2018 | 4.32% | (8.38) |
| FY2017 | 12.7% | 2.50 |
| FY2016 | 10.2% | 2.47 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| ATR AptarGroup, Inc. compare | 9.86% |
| COO The Cooper Companies, Inc. | 6.84% |
| AVTR Avantor, Inc. compare | 5.91% |
| SOLV Solventum Corporation compare | 3.19% |
| ALGN Align Technology, Inc. compare | 0.00% |
| RGEN Repligen Corporation compare | −0.57% |
| BLCO Bausch + Lomb Corporation compare | −1.71% |
| BAX Baxter International Inc. compare | −10.6% |
| TFX Teleflex Incorporated compare | −28.9% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on COO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement